Glucagon-like peptide-1 (GLP-1) is a weekly injectable medication that stimulates insulin release, slows gastric motility, reduces appetite, and stabilizes blood sugar
Semaglutide (Wegovy for weight management, Ozempic for diabetes) produces significant weight reduction, but like all substantial weight loss, it includes some lean body mass reduction alongside fat loss
Maria Martinez Maria is responsible for the overall financial strategy, planning, and management to support the practices long-term success
The net effect is a significant reduction in caloric intake without requiring conscious restriction at every meal which is why clinical trial weight loss outcomes with semaglutide are substantially larger than those achieved by diet alone
& Derkinderen, P
Administration of exogenous melatonin improves the diurnal rhythms of the gut microbiota in mice fed a high-fat diet (2020) 5:e00112-20